D. E. Shaw & Co., Inc. Abbott Laboratories Call Options Transaction History

D. E. Shaw & Co., Inc.

  • $107 Billion
  • Q3 2024

Call Options

23 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$100.73 - $112.44 $19.6 Million - $21.9 Million
-194,500 Reduced 95.67%
8,800 $914,000
Q1 2024

May 15, 2024
BUY
$109.52 - $120.96 $1.53 Million - $1.69 Million
14,000 Added 7.4%
203,300 $23.1 Million
Q4 2023

Feb 14, 2024
BUY
$90.19 - $110.4 $6.33 Million - $7.75 Million
70,200 Added 58.94%
189,300 $20.8 Million
Q3 2023

Nov 14, 2023
BUY
$95.53 - $114.62 $4.71 Million - $5.65 Million
49,300 Added 70.63%
119,100 $11.5 Million
Q2 2023

Aug 14, 2023
SELL
$100.78 - $112.29 $12.8 Million - $14.3 Million
-127,200 Reduced 64.57%
69,800 $7.61 Million
Q1 2023

May 15, 2023
BUY
$96.86 - $114.01 $1.82 Million - $2.14 Million
18,800 Added 10.55%
197,000 $19.9 Million
Q4 2022

Feb 14, 2023
BUY
$95.06 - $111.52 $16.9 Million - $19.9 Million
178,200 New
178,200 $19.6 Million
Q1 2022

May 16, 2022
BUY
$114.02 - $139.04 $4.29 Million - $5.23 Million
37,600 Added 18.16%
244,700 $29 Million
Q4 2021

Feb 14, 2022
BUY
$115.53 - $141.46 $18.1 Million - $22.2 Million
157,100 Added 314.2%
207,100 $29.1 Million
Q3 2021

Nov 15, 2021
BUY
$116.66 - $129.06 $2.92 Million - $3.23 Million
25,000 Added 100.0%
50,000 $5.91 Million
Q1 2021

May 17, 2021
SELL
$108.84 - $128.23 $8.16 Million - $9.62 Million
-75,000 Reduced 75.0%
25,000 $3 Million
Q4 2020

Feb 16, 2021
BUY
$105.0 - $114.42 $3.07 Million - $3.34 Million
29,200 Added 41.24%
100,000 $10.9 Million
Q3 2020

Nov 16, 2020
SELL
$91.64 - $111.29 $3.86 Million - $4.69 Million
-42,100 Reduced 37.29%
70,800 $7.71 Million
Q1 2020

May 15, 2020
SELL
$62.82 - $91.86 $13 Million - $19.1 Million
-207,700 Reduced 64.78%
112,900 $8.91 Million
Q4 2019

Feb 14, 2020
BUY
$78.51 - $87.4 $6.86 Million - $7.64 Million
87,400 Added 37.48%
320,600 $27.8 Million
Q3 2019

Nov 14, 2019
BUY
$81.84 - $88.74 $12.6 Million - $13.6 Million
153,600 Added 192.96%
233,200 $19.5 Million
Q2 2019

Aug 14, 2019
BUY
$72.88 - $85.0 $2.32 Million - $2.7 Million
31,800 Added 66.53%
79,600 $6.69 Million
Q1 2019

May 15, 2019
SELL
$66.22 - $80.06 $893,970 - $1.08 Million
-13,500 Reduced 22.02%
47,800 $3.82 Million
Q3 2018

Nov 14, 2018
SELL
$60.81 - $73.36 $1.31 Million - $1.58 Million
-21,600 Reduced 26.06%
61,300 $4.5 Million
Q2 2018

Aug 14, 2018
SELL
$57.57 - $63.54 $2.83 Million - $3.12 Million
-49,100 Reduced 37.2%
82,900 $5.06 Million
Q1 2018

May 15, 2018
SELL
$56.27 - $63.62 $2.06 Million - $2.33 Million
-36,600 Reduced 21.71%
132,000 $7.91 Million
Q4 2017

Feb 14, 2018
SELL
$53.68 - $57.47 $1.69 Million - $1.8 Million
-31,400 Reduced 15.7%
168,600 $9.62 Million
Q3 2017

Nov 14, 2017
BUY
$48.06 - $53.64 $9.61 Million - $10.7 Million
200,000
200,000 $10.7 Million

Others Institutions Holding ABT

# of Institutions
3,204
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $219B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email